YASOO Receives Patent Notification

March 1, 2004

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal


YASOO Receives Patent Notification

JOHNSON CITY, Tenn. YASOO Health received notice from the U.S.Patent & Trademark Office that it has allowed the claims filed for itstocopherol ester derivative with selenium and other minerals; the patent shouldbe issued later this year. The application covered 15 health and researchapplications for treatment of cancer, according to YASOO. This approvedpatent and six other pending patent applications underscore our commitment tothe science of good health, said Konstantinos Papas, M.D., medical directorof YASOO (www.yasoo.com).

In addition, YASOO completed a Small Business Innovation Research (SBIR)grant proposal to develop proprietary formulations to treat malabsorption incystic fibrosis patients. According to Papas, the company will start a Phase Iclinical trial by early spring.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like